AKT1 and T-cell acute lymphoblastic leukemia: In addition, LINC00665 can compete with miR-101 to enhance the viability, migration, and invasion of cancer cells in T-cell acute lymphoblastic leukemia by activating the PI3K/Akt signaling pathway [42].